This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Goal: The goal of this project is to demonstrate the utility of hyperpolarized [1-13C]-pyruvate magnetic resonance spectroscopic imaging (MRSI) as in vivo reporter of enzyme kinetics involved in the biosynthesis pathways of pyruvate. Our long-term goal is to utilize this technique for validating potential therapeutic targets that regulate protein function in vivo with the precision and control conferred by tunable gene technology, and in addition advance our understanding of basic biochemical pathways. We assume that NADH reductase is the key enzyme that regulates (rate limiting step) the NADH to NAD+ reduction. Materials and Methods: EL4 (C57BL mouse lymphoma) and A20 (BALB/c B cell lymphoma) cells are transfected with cDNA plasmid of NQO1. These cells have been tested and found negative for ectromelia virus (mousepox). The cDNA plasmid of NQO1 expresses the gene for nicotinamide adenine dinucleotide (NADH) quinone oxidoreductase 1 (NQO1). NQO1 is a ubiquitous cytosolic flavoenzyme that catalyzes two- electron reduction of various quinones, with NADH or NADPH as an electron donor. A flask of 50 million cells in 2.5 ml of RPMI 1640 medium is administered with hyperpolarized [1-13C]-pyruvate followed by data acquisition. A 3.0 Tesla Signa magnet (GE healthcare) and a dynamic nuclear polarizer (Oxford Instruments Hypersense) are utilized.
Specific Aim 1 : To transfect cell cultures with a NADH-reductase gene that over-expresses NADH. Experiment Design 1: We will transfect cells with cDNA plasmids that increases the levels of NADH in cell culture, and we will measure the chemical flux of [1-13C]-pyruvate to lactate as an indirect measure of the NADH levels. However, since hyperpolarized [1-13C]-pyruvate signal is short lived (~30s) we will prefer a regulated promoter gene of NADH-reductase that can be turned on appropriately prior to the infusion of hyperpolarized pyruvate.
Specific Aim 2 : To ectopically expressed a plasmid DNA reporter or a tunable regulated gene of NADH reductase in rat liver. Experimental Design 2: We will transfect a rat liver by hydrodynamics-based administration of plasmid DNA or by systemic delivery of conditionally regulated protein. When NADH levels are significantly higher in the liver, the hyperpolarized [1-13C]-pyruvate experiment will be performed to ascertain the conversion rates of pyruvate to lactate as an indirect measure of NADH-reductase. As a control measure, one cohort of rats will not receive the plasmid DNA or tunable form of NADH-reductase.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR009784-15
Application #
7955395
Study Section
Special Emphasis Panel (ZRG1-SBIB-F (40))
Project Start
2009-06-01
Project End
2010-05-31
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
15
Fiscal Year
2009
Total Cost
$18,046
Indirect Cost
Name
Stanford University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Maclaren, Julian; Aksoy, Murat; Ooi, Melvyn B et al. (2018) Prospective motion correction using coil-mounted cameras: Cross-calibration considerations. Magn Reson Med 79:1911-1921
Guo, Jia; Holdsworth, Samantha J; Fan, Audrey P et al. (2018) Comparing accuracy and reproducibility of sequential and Hadamard-encoded multidelay pseudocontinuous arterial spin labeling for measuring cerebral blood flow and arterial transit time in healthy subjects: A simulation and in vivo study. J Magn Reson Imaging 47:1119-1132
Tamir, Jonathan I; Uecker, Martin; Chen, Weitian et al. (2017) T2 shuffling: Sharp, multicontrast, volumetric fast spin-echo imaging. Magn Reson Med 77:180-195
Lai, Lillian M; Cheng, Joseph Y; Alley, Marcus T et al. (2017) Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia. J Magn Reson Imaging 45:1407-1418
Taviani, Valentina; Alley, Marcus T; Banerjee, Suchandrima et al. (2017) High-resolution diffusion-weighted imaging of the breast with multiband 2D radiofrequency pulses and a generalized parallel imaging reconstruction. Magn Reson Med 77:209-220
Uecker, Martin; Lustig, Michael (2017) Estimating absolute-phase maps using ESPIRiT and virtual conjugate coils. Magn Reson Med 77:1201-1207
Kogan, Feliks; Hargreaves, Brian A; Gold, Garry E (2017) Volumetric multislice gagCEST imaging of articular cartilage: Optimization and comparison with T1rho. Magn Reson Med 77:1134-1141
Aksoy, Murat; Maclaren, Julian; Bammer, Roland (2017) Prospective motion correction for 3D pseudo-continuous arterial spin labeling using an external optical tracking system. Magn Reson Imaging 39:44-52
Bian, W; Tranvinh, E; Tourdias, T et al. (2016) In Vivo 7T MR Quantitative Susceptibility Mapping Reveals Opposite Susceptibility Contrast between Cortical and White Matter Lesions in Multiple Sclerosis. AJNR Am J Neuroradiol 37:1808-1815
Vos, Sjoerd B; Aksoy, Murat; Han, Zhaoying et al. (2016) Trade-off between angular and spatial resolutions in in vivo fiber tractography. Neuroimage 129:117-132

Showing the most recent 10 out of 446 publications